Zusammenfassung
Obwohl die Oberflächenanatomie der Leber schon bereits 2000 Jahre v. Chr. beschrieben wurde, wurden erst am Ende des 19. Jahrhunderts die ersten Cholezystektomien in Europa durchgeführt. Eine wahre Leberchirurgie hat sich erst in den 1950er-Jahren entwickelt, wegen der „brüchigen Gewebestruktur und der reichlichen Blutversorgung“ des Organs, wie es J. W. Elliot 1897 beschreibt, und dies auch nur mit einer sehr hohen Letalität und Komplikationsrate. Eine Leber- und Gallenwegschirurgie mit akzeptabler Komplikationsrate hat sich dann ab den 1980er-Jahren etabliert. Dieses Kapitel stellt die Grundlagen der benignen und malignen Erkrankungen der Leber und der Gallenwege dar und versucht, die Ansprüche einer hochqualitativen und komplikationsarmen chirurgischen Therapie zu vermitteln. Ein besonderer Teil des Kapitels ist der Lebertransplantation gewidmet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Literatur zu Abschn. 8.1 und 8.4
Belghiti et al (2000) The Brisbane terminology of liver anatomy and resections HPB 2:333–9
Literatur zu Abschn. 8.2
Scott-Conner CEH (2002) Chassin’s operative strategy in general surgery. An expositive atlas, 3. Aufl. Springer, New York
Literatur zu Abschn. 8.5
Gutt CN, Encke J, Köninger J, Harnoss JC, Weigand K, Kipfmüller K, Schunter O, Götze T, Golling MT, Menges M, Klar E, Feilhauer K, Zoller WG, Ridwelski K, Ackmann S, Baron A, Schön MR, Seitz HK, Daniel D, Stremmel W, Büchler MW (2013) Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg 258:385–393
Zusätzliche Literatur die Im Text mit Buchstaben belegt ist – z. B. (Kniepeiss et al. 2020a)
Houben P, Büchler MW, Schemmer P (2014) Use of an electrothermal bipolar vessel sealing device during recipient hepatectomy for liver transplantation. J Am Coll Surg 219(5):e59–e63
Kniepeiss D, Schemmer P (2020) Transplantation bei Lebermetastasen neuroendokriner Tumoren – Heilung oder Palliation? J Klein Endokrinol Stoffw 13:54–58
Kniepeiss D, Stiegler P, Talakic E, Schemmer P (2020d) Anterior approach for hepatectomy before piggy-back liver transplantation in giant polycystic liver disease. Liver Transpl. https://doi.org/10.1002/lt.25824. Online ahead of print
Lin S, Hoffmann K, Schemmer P (2012) Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 1(3–4):144–158
de Santibañes E, Ardiles V, Alvarez FA, Busnelli VC, de Santibañes M (2017) Extreme hepatic surgery and other strategies. Springer, Heidelberg, Germany
Schemmer P, Friess H, Hinz U, Mehrabi A, Kraus TW, Z’graggen K, Schmidt J, Uhl W, Büchler MW (2006) Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg 30(3):419–430
Weiterführende Literatur
Literatur zu Abschn. 8.1 und 8.4
von Lanz T, Wachsmuth W (2004) Praktische Anatomie, Bauch. Springer, Berlin/Heidelberg
Standring S (2009) Gray’s anatomy. The anatomical basis of clinical practice, 40. Aufl. Churchill Livingstone, Elsevier, London
Zilles K, Tillmann BN (2010) Anatomie. Springer, Berlin/Heidelberg
Literatur zu Abschn. 8.2
Adam R, Kitano Y, Abdelrafee A, Allard MA, Baba H (2020) Debulking surgery for colorectal liver metastases: foolish or chance? Surg Oncol 33:266–269
Arroyo V, Moreau R, Jalan R (2020) Acute-on-chronic liver failure. N Engl J Med 382:2137–2145
Asencio JM, Sabrido JLG, Olmedilla L (2014) How to expand the safe limits in hepatic resections? J Hepatobiliary Pancreat Sci 21:399–404
Baili E, Tsilimigras DI, Moris D, Sahara K, Pawlik TM (2020) Technical modifications and outcomes after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for primary liver malignancies: a systematic review. Surg Oncol 33:70–80
Cai W, Liu Z, Xiao Y, Zhang W, Tang D, Cheng B, Li Q (2019) Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis. Surg Endosc 33:3550–3557
Caruso S, O’Brien DR, Cleary SP, Roberts LR, Zucman-Rossi J (2020) Genetics of HCC: novel approaches to explore molecular diversity. Hepatology. https://doi.org/10.1002/hep.31394
De’Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canuï-Poitrine F, Liuu E (2020) Surgical and regional treatments for colorectal cancer metastases in older patients: a systematic review and meta-analysis. PLoS One. https://doi.org/10.1371/journal.pone.0230914
Di Martino M, Rompianesi G, Mora-Guzmán I, Martín-Pérez E, Montati R, Troisi RI (2020) Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases. Eur J Surg Oncol 46:772–781
Dufour JF, Caussy C, Loomba R (2020) Combination therapy for non-alcoholic steatohepatitis: ratinale, opportunities and challenges. Gut. https://doi.org/10.1136/gutjnl-2019-319104
Gangi A, Howe JR (2020) The Landmark series: neuroendocrine tumor liver metastases. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-08787
Gavriilidis P, Roberts KJ, Aldrighetti L, Sutcliffe RP (2020) A comparison between robotic, laparoscopic and open hepatectomy: a systematic review and network meta-analysis. Eur J Surg Oncol 46:1214–1224
Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C (2012) How much remnant is enough in liver resection? Dig Surg 29:6–17
Jarnagin WR (2012) Blumgart’s surgery of the liver, biliary tract and pancreas, 5. Aufl. Elsevier, Philadelphia
Kokudo T, Hasegawa K, Shirata C, Tanimoto M, Ishizawa T, Kaneko J, Akamatsu N, Arita J, Demartines N, Uldry E, Kokudo N, Halkic N (2019) Assessment of preoperative liver function for surgical resection in patients with hepatocellular carcinoma. Liver Cancer 8:447–456
Lafaro KJ, Stewart C, Fong A, Fong Y (2020) Robotic liver resection. Surg Clin North Am 100:265–281
Lang H, Huber T (2020) Virtual and augmented reality in liver surgery. Ann Surg 271:e8
Lin XJ, Yang J, Chen XB, Zhang M, Xu MQ (2014) The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. J Surg Res 188:489–495
Michal K, Sau M, Tamara GMH, Long JR (2020) A better route to ALPPS: minimally invasive vs open ALPPS. Surg Endosc 34:2379–2389
Rashidian N, Alseidi A, Kirks RC (2020) Cancers metastatic to the liver. Surg Clin N Am 100:551–563
Ren L, Zhu D, Benson AB 3rd, Nordlinger B, Koehne CH, Delaney CP, Kerr D, Lenz HJ, Fan J, Wang J, Gu J, Li J, Shen L, Tsarkov P, Tejpar S, Zheng S, Zhang S, Gruenberger T, Qin X, Wang X, Zhang Z, Poston GJ, Xu J, SINCE Group (2020) Shangai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). Eur J Surg Oncol 46:955–966
Sakon M, Kobayashi S, Wada H, Eguchi H, Marubashi S, Takahashi H, Akita H, Gotoh K, Yamada D, Asukai K, Hasegawa S, Ohue M, Yano M, Nagano H (2020) „Logic-based Medicine“ is more feasible than „evidence-based medicine“ in the local treatment for hepatocellular carcinoma. Oncology 98:259–266
Schoening WN, Denecke T, Neumann UP (2015) Präoperative Bildgebung/Operationsplanung für die Leberchirurgie. Chirurg 86:1167–1182
Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review. JAMA 323:1175–1183
Stravitz RT, Lee WM (2019) Acute liver failure. Lancet 394:869–881
Troisi RI, Pegoraro F, Giglio MC, Rompianesi G, Berardi G, Tomassini F, De Simone G, Aprea G, Montalti R, De Palma GD (2020) Robotic approach to the liver: open surgery in a closed abdomen laparoscopic surgery with technical constraints? Surg Oncol 33:239–248
Literatur zu Abschn. 8.3
Best LM, Leung J, Freeman SC, Sutton AJ, Cooper NJ, Milne EJ, Cowlin M, Payne A, Walshaw D, Thorburn D, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS (2020) Induction immunosuppression in adult undergoing liver transplantation: a network meta-analysis. Cochrane Database Syst Rev 1:CD013203
Cho HD, Samstein B, Chaundry S, Kim KH (2020) Minimally invasive donor hepatectomy, systemic review. Int J Surg. https://doi.org/10.1016/j.ijsu.2020.06.023
Chu KK, Wong KH, Chok KS (2020) Expanding indications for liver transplant: tumor and patient factors. Gut Liver. https://doi.org/10.5009/gnl19265
Edgar L, Pu T, Porter B, Aziz JM, La Pointe C, Asthana A, Orlando G (2020) Regenerative medicine, organ bioengenering and transplantation. Br J Surg 107:793–800
Fatourou EM, Tsochatzis EA (2019) Management of metabolic syndrome and cardiovascular risk after liver transplantation. Lancet Gastroenterol Hepatol 4:731–741
Im GY, Neuberger J (2020) Debate on selection criteria for liver transplantation for alcoholic hepatitis: tighten or loosen? Liver Transpl 26:916–921
Jung KW, Kang J, Kwon HM, Moon YJ, Jun IG, Song JG, Hwang GS (2019) Effects of remote ischemic preconditioning conducted in living liver donors on postoperative liver function in donors and recipients following liver transplantation: a randomized clinical trial. Ann Surg 271:646–653
Kohut TJ, Barandiaran JF, Keating BJ (2020) Genomics and liver transplantation: genomic biomarkers for the diagnosis of acute cellular rejection. Liver Transpl. https://doi.org/10.1002/lt.25812
Lee TC, Kaiser TE, Alloway R, Woodle ES, Edwards MJ, Shah SA (2019) Telemedicine based remote home monitoring after liver transplantation: results of a randomized prospective trial. Ann Surg 270:564–572
Lingiah VA, Niazi M, Olivo R, Paterno F, Guarrera JV, Pyrsopoulos NT (2020) Liver transplantation beyond Milan criteria. J Clin Transl Hepatol 8:69–75
Mathurin P, Lucey MR (2020) Liver transplantation in patients with alcohol-related liver disease: current status and future directions. Lancet Gastroenterol Hepatol 5:507–514
Nickkholgh A, Nikdad M, Shafie S, Abbasi Dezfoui S, Mehrabi A, Eason JD, Mas VR, Maluf DG (2019) Ex situ liver machine perfusion as an emerging graft protective strategy in clinical liver transplantation: the Dawn of a new era. Transplantation 103:2003–2011
Rauber A, Kopsch F (1987) Lehrbuch und Atlas der Anatomie des Menschen, Bd 2: Innere Organe. Thieme, Stuttgart
Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edminson B, Boeckh M, Limaye AP (2020) Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial. JAMA 323:1378–1387
Trebicka J, Sundaram V, Moreau R, Jalan R, Arroyo V (2020) Liver transplantation for acute-on-chronic liver failure: science or fiction? Liver Transpl 26:906–915
Vierling JM, Kerkar N, Czaja AJ, Mack CL, Adams D, Assis D, Manns M, Mayo M, Nayfeh T, Majzoub AMM, Alzuabi MA, Ding J, Haffar S, Murad MH, Alsawas M (2020) Immunosuppressive treatment regiments in autoimmune hepatitis: systematic reviews and meta-analysis supporting AASLD guidelines. Hepatology. https://doi.org/10.1002/hep.31407
Weisenbacher A, Vrakas G, Nasralla D, Ceresa CDL (2019) The future of organ perfusion and re-conditioning. Transpl Int 32:586–597
Zhou J, Chen J, Wie Q, Saeb-Parsy K, Xu X (2020) The role of ischemia-reperfusion injury in early hepatic allograft dysfunction. Liver Transpl. https://doi.org/10.1002/lt.25779
Literatur zu Abschn. 8.5
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ (2020) Nat Rev Gastroenterol Hepatol. https://doi.org/10.1038/s41575-020-0310
Castaing D, Azoulay D, Adam R (2006) Chirurgie du foie et de l’hypertension portale. Elsevier, Masson Paris
Gentile D, Donadon M, Lleo A, Aghemo A, Roncalli M, di Tommaso L, Torzilli G (2020) Surgical treatment of hepatocholangiocarcinoma: a systematic review. Liver Cancer 9:15–27
Jung KW, Kang J, Kwon HM, Moon YJ, Jun IG, Song JG, Hwang GS (2020) Effect of remote ischemic preconditioning conducted in living liver donors on postoperative liver function in donors and recipients following liver transplantation: a randomized clinical trial. Ann Surg 271:646–653
Ke Q, Lin N, Deng M, Wang L, Zeng Y, Liu J (2020) The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: a systematic review and meta-analysis. PLoS One 15:e0229292
Massironi S, Pilla L, Elvevi A, Longarini R, Rossi RE, Bidoli P, Invernizzi P (2020) New emerging systemic therapeutic options for advanced cholangiocarcinoma. Cell 9:688
Mejia JC, Pasko J (2020) Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg Clin North Am 100:535–549
Moris D, Kostakis ID, Machairas N, Prodromidou A, Tsilimigras DI, Ravindra KV, Sudan DL, Knechtle SJ, Barbas AS (2019) Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis. PLoS One 14:e0220527
Nikkholgh A, Nikdad M, Shafie S, Abbasi Dezfouli S, Mehrabi A, Eason JD, Mas VR, Maluf DG (2019) Ex situ machine perfusion as an emerging graft protective strategy in clinical liver transplantation: the Dawn of an era. Transplantation 103:2003–2011
Panayotova GG, Paterno F, Guarrera JV, Lunsford KE (2020) Liver transplantation for cholangiocarcinoma: insights into the prognosis and the evolving indications. Curr Oncol Rep 22:49
Zusätzliche Literatur die Im Text mit Buchstaben belegt ist – z. B. (Kniepeiss et al. 2020a)
Kniepeiss D, Talakic E, Schemmer P (2020a) Echinococcus granulosus: a novel parenchymal sparing surgical treatment. Hepatobiliary Pancreat Dis Int 19(4):390–393
Kniepeiss D, Rosenkranz AR, Fickert P, Schemmer P (2020b) Update Immunsuppression bei Organtransplantation. Allgemein Viszeralchirurgie up2date 14:223–235
Kniepeiss D, Talakic E, Schemmer P (2020c) Interventionelle und chirurgische Therapie non-kolorektaler Lebermetastasen. Allgemein Viszeralchirurgie up2date 14:379–395
Kremer M, Manzini G, Hristov B, Polychronidis G, Mokry T, Sommer CM, Mehrabi A, Weitz J, Büchler MW, Schemmer P (2015) Impact of neoadjuvant chemotherapy on hypertrophy of the future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy. J Am Coll Surg 221(3):717–728
Kvietkauskas M, Zitkute V, Leber B, Strupas K, Stiegler P, Schemmer P (2020) The role of metabolomics in current concepts of organ preservation. Int J Mol Sci 21(18):E6607
Mayer P, Grözinger M, Mokry T, Schemmer P, Waldburger N, Kauczor HU, Klauss M, Sommer CM (2019) Semi-automated computed tomography Volumetry can predict hemihepatectomy specimens' volumes in patients with hepatic malignancy. BMC Med Imaging 19(1):20
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Hoffmann, K., Schemmer, P. (2021). Leber, Gallenblase und Gallenwege. In: Billmann, F., Keck, T. (eds) Facharztwissen Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61520-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-61520-1_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-61519-5
Online ISBN: 978-3-662-61520-1
eBook Packages: Medicine (German Language)